Literature DB >> 19764256

Physiological modes of action of fluoxetine and its human metabolites in algae.

Judith Neuwoehner1, Kathrin Fenner, Beate I Escher.   

Abstract

Fluoxetine, the active ingredient of many antidepressants, was identified as specifically toxic toward algae in a quantitative structure-activity relationship (QSAR) analysis with literature data for algae, daphnia, and fish. The goal of this study was to elucidate the mode of action in algae and to evaluate the toxicity of the major human metabolites of fluoxetine using two different algae tests. The time dependence and sensitivity of thedifferenteffectendpointsyield information on the physiological mode of action. Baseline toxicity was predicted with QSARs based on measured liposome-water partition coefficients. The ratio of predicted baseline toxicity to experimental toxicity (toxic ratio TR) gives information on the intrinsic potency (extent of specificity of effect). The metabolite p-trifluoromethylphenol was classified to act as baseline toxicant Fluoxetine (TR 60-150) and its pharmacologically active metabolite norfluoxetine (TR 10-80) exhibited specific toxicity. By comparison with reference compounds we conclude that fluoxetine and norfluoxetine have an effect on the energy budget of algal cells since the time pattern of these two compounds is most similar to that observed for norflurazon, but they act less specifically as indicated by lower TR values and the similarity of the effect pattern to baseline toxicants. The mixture toxicity of fluoxetine and its human metabolites norfluoxetine and p-TFMP can be predicted using the model of concentration addition for practical purposes of risk assessment despite small deviations from this model for the specific endpoints like PSII inhibition because the integrative endpoints like growth rate and reproduction in all cases gave agreement with the predictions for concentration addition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764256     DOI: 10.1021/es9005493

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  7 in total

1.  Consumption-based approach for predicting environmental risk in Greece due to the presence of antimicrobials in domestic wastewater.

Authors:  Evangelia I Iatrou; Athanasios S Stasinakis; Nikolaos S Thomaidis
Journal:  Environ Sci Pollut Res Int       Date:  2014-07-02       Impact factor: 4.223

2.  Photosynthetic sensitivity of phytoplankton to commonly used pharmaceuticals and its dependence on cellular phosphorus status.

Authors:  Malgorzata Grzesiuk; Alexander Wacker; Elly Spijkerman
Journal:  Ecotoxicology       Date:  2016-02-19       Impact factor: 2.823

3.  Effect of metformin exposure on growth and photosynthetic performance in the unicellular freshwater chlorophyte, Chlorella vulgaris.

Authors:  Brittany M Cummings; Joseph A Needoba; Tawnya D Peterson
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

4.  Implications of PFAS definitions using fluorinated pharmaceuticals.

Authors:  Emily Hammel; Thomas F Webster; Rich Gurney; Wendy Heiger-Bernays
Journal:  iScience       Date:  2022-03-02

Review 5.  Selected Pharmaceuticals in Different Aquatic Compartments: Part II-Toxicity and Environmental Risk Assessment.

Authors:  André Pereira; Liliana Silva; Célia Laranjeiro; Celeste Lino; Angelina Pena
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

6.  Sensitivities of seven algal species to triclosan, fluoxetine and their mixtures.

Authors:  Ran Bi; Xiangfeng Zeng; Lei Mu; Liping Hou; Wenhua Liu; Ping Li; Hongxing Chen; Dan Li; Agnes Bouchez; Jiaxi Tang; Lingtian Xie
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

7.  Fluoxetine Removal from Aqueous Solutions Using a Lignocellulosic Substrate Colonized by the White-Rot Fungus Pleurotus ostreatus.

Authors:  Andreia D M Silva; Juliana Sousa; Malin Hultberg; Sónia A Figueiredo; Olga M Freitas; Cristina Delerue-Matos
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.